Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTyman Regulatory News (TYMN)

  • This share is currently suspended. It was suspended at a price of 398.00
  • There is currently no data for TYMN

Director/PDMR Shareholding

24 Apr 2024 17:02

RNS Number : 9187L
Tyman PLC
24 April 2024
 

TYMAN PLC

("Tyman" or the "Company" or the "Group")

 

DIRECTOR/PDMR SHAREHOLDINGS

 

Tyman plc announces that it has been notified of the following transactions in the Company's ordinary 5p shares ("Shares") undertaken by an Executive Director and PDMR, Jason Ashton, CFO.

 

DEFERRED SHARE BONUS PLAN (THE "DSBP")

 

On 23 April 2024, following the end of a closed period, the Company's Remuneration Committee granted the following nil-cost option over Shares (the "2023 Award") to Jason Ashton, an Executive Director of the Company, under the terms of the Company's DSBP 2023 (as part of the annual bonuses for the year ended 31 December 2023). Under the terms of the DSBP, 50% of the bonuses of Executive Directors, which would otherwise have been payable in cash, are delivered in the form of nil-cost option.

Executive Director

Number of Ordinary Shares subject to the DSBP award1

Jason Ashton

82,908

1As customary for Tyman, the number of Shares were calculated by reference to the 5-day average closing price prior to the date that shares were awarded (5 trading days ended 13th March 2024) of £2.861.

 

This 2023 Award would normally vest (together with dividend equivalents in cash or Shares) following the publication of the Group's audited results for the year ending 31 December 2026, expected to be in March 2027. No consideration was paid for the 2023 Awards and no consideration is due to be payable on vesting.

Impact of the recommended offer for the Company

On 22 April 2024, the boards of Quanex Building Products Corporation ("Quanex") and Tyman announced (the "2.7 Announcement") that they reached agreement on the terms of a recommended cash and share offer, pursuant to which Quanex will acquire the entire issued and to be issued ordinary share capital of Tyman (the "Transaction"). In this section, all capitalised terms used shall have the same meaning as in the 2.7 Announcement, unless expressly defined otherwise.

Pursuant to the terms agreed by Quanex and Tyman, awards under the DSBP shall vest or become exercisable in full on the Effective Date. Awards under the DSBP will accrue, in the ordinary course, dividend equivalents that will be settled by Tyman in cash if they have not already been credited in Shares.

The following disclosure is made in accordance with Article 19 of EU Market Abuse Regulation No. 596/2014 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018.

 

 

1

 

Details of the persons discharging managerial responsibilities / person closely associated

 

 

a)

 

Names

 

i. JASON ASHTON

 

 

2

 

Reason for the notification: GRANT OF OPTIONS

 

 

a)

 

Position/status

 

i. CHIEF FINANCIAL OFFICER

 

 

b)

 

Initial notification /Amendment

 

INITIAL NOTIFICATION

 

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

 

a)

 

Name

 

TYMAN PLC

 

b)

 

LEI

 

213800AAFUV5PKGQU848

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

 

a)

 

Description of the financial instrument, type of instrument

ORDINARY SHARES OF 5P EACH

 

 

 

Identification code

ISIN NUMBER:GB00B29H4253

 

 

b)

 

Nature of the transaction

A.  GRANT OF DSBP SHARES.

 

 

 

c)

Prices (s) and volume(s)

Price

Volume

 

Nil

82, 908

 

 

d)

 

Aggregated information

 

 

- Aggregated volume

· 82,908

 

 

 

 

- Price

· Nil

 

 

 

e)

 

Date of the transaction

 

23 April 2024

 

f)

 

Place of the transaction

LONDON STOCK EXCHANGE

 

 

 

 

24 April 2024

 

 

Enquiries:

 

Tyman plc

020 7976 8000

 

Peter Ho - General Counsel & Company Secretary

www.tymanplc.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHQZLFLZZLBBBF
Date   Source Headline
5th Oct 20225:01 pmRNSHolding(s) in Company
5th Oct 20225:00 pmRNSHolding(s) in Company
5th Oct 20224:04 pmRNSHolding(s) in Company
19th Aug 20223:33 pmRNSHolding(s) in Company
1st Aug 20223:34 pmRNSHolding(s) in Company
26th Jul 20227:00 amRNSHalf-year Report
17th Jun 20224:23 pmRNSHolding(s) in Company
6th Jun 20228:08 amRNSDirector/PDMR Shareholding
24th May 20229:57 amRNSDirector/PDMR Shareholding
19th May 20224:41 pmRNSDirector/PDMR Shareholding
19th May 20224:40 pmRNSResult of AGM
19th May 20227:00 amRNSAGM Trading Update
26th Apr 20225:14 pmRNSHolding(s) in Company
25th Apr 20223:36 pmRNSHolding(s) in Company
20th Apr 20223:59 pmRNSDirector/PDMR Shareholding
11th Apr 202211:30 amRNSDirector/PDMR Shareholding
1st Apr 20224:00 pmRNSHolding(s) in Company
1st Apr 20227:00 amRNSNotice of AGM
31st Mar 20229:56 amRNSHolding(s) in Company
31st Mar 20229:51 amRNSHolding(s) in Company
29th Mar 20223:07 pmRNSHolding(s) in Company
29th Mar 202212:00 pmRNSEBT Purchase
29th Mar 202210:54 amRNSHolding(s) in Company
15th Mar 20227:00 amRNSRefinancing of US Private Placement Notes
10th Mar 20223:12 pmRNSDirector/PDMR Shareholding
10th Mar 20222:43 pmRNSHolding(s) in Company
8th Mar 202212:09 pmRNSHolding(s) in Company
3rd Mar 20223:21 pmRNSDirector/PDMR Shareholding
3rd Mar 20227:00 amRNSFinal Results
22nd Feb 20224:10 pmRNSNotice of Results
25th Jan 202210:05 amRNSDirector Declaration
16th Dec 20217:00 amRNSNew Non-Executive Director
25th Nov 202112:57 pmRNSTotal Voting Rights
17th Nov 20217:00 amRNSTrading Update
28th Oct 20219:43 amRNSHolding(s) in Company
14th Sep 20217:49 amRNSHolding(s) in Company
13th Aug 202110:21 amRNSChange of Auditor
30th Jul 20213:28 pmRNSHolding(s) in Company
27th Jul 20217:00 amRNSHalf-year Report
2nd Jun 202112:06 pmRNSHolding(s) in Company
2nd Jun 202112:00 pmRNSHolding(s) in Company
1st Jun 20214:12 pmRNSHolding(s) in Company
1st Jun 20213:53 pmRNSHolding(s) in Company
25th May 20215:30 pmRNSRSA Insurance Group
24th May 20213:22 pmRNSDirector/PDMR Shareholding
20th May 20214:39 pmRNSResult of AGM
20th May 20217:00 amRNSCapital Markets Event
13th May 20214:45 pmRNSHolding(s) in Company
11th May 20214:38 pmRNSHolding(s) in Company
10th May 20214:41 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.